Vaccines, blood, antisera, toxins and cultures in United States

About

Exports In 2023, United States exported $52.2B in Vaccines, blood, antisera, toxins and cultures, making it the 1st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in United States. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United States are: Germany ($7.08B), Belgium ($6.91B), China ($4.02B), Japan ($3.97B), and Switzerland ($3.96B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United States between 2022 and 2023 were Belgium ($4.4B), Germany ($872M), and Austria ($727M).

Imports In 2023, United States imported $79.7B in Vaccines, blood, antisera, toxins and cultures, becoming the 1st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in United States. United States imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($18.3B), Germany ($12.4B), Netherlands ($9.01B), Switzerland ($7.17B), and Singapore ($6.15B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United States between 2022 and 2023 were Netherlands ($5.09B), Germany ($3.57B), and Singapore ($3.49B).

COMPANIES In 2023, leading companies such as Amazon (6), Tesla (5), and Costco Wholesale (2) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures to the United States.

Latest Trends

November 2024

About

Overview In November 2024 United States' Vaccines, blood, antisera, toxins and cultures exports accounted up to $4.14B and imports accounted up to $8.51B, resulting in a negative trade balance of $4.37B. Between November 2023 and November 2024 the exports of United States' Vaccines, blood, antisera, toxins and cultures have increased by $201M (5.12%) from $3.94B to $4.14B, while imports increased by $1.55B (22.3%) from $6.96B to $8.51B.

Destinations In November 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to Germany ($562M), Netherlands ($552M), Ireland ($332M), Japan ($316M), and China ($299M), and were imported mostly from Ireland ($3.09B), Singapore ($961M), Germany ($829M), Belgium ($700M), and Italy ($625M).

Growth In November 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Belgium ($771M or 391%), Netherlands ($272M or 132%), and China ($245M or 221%). In November 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Netherlands ($663M or 375%), Ireland ($572M or 41.4%), and Germany ($379M or 60.8%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (November 2023 - November 2024)$201M(5.12%)

IMPORT GROWTH (November 2023 - November 2024)$1.55B(22.3%)

MAIN EXPORTER (November 2024)Puerto Rico$1.76B

MAIN DESTINATION (November 2024)Germany$562M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download